Work

Real‐world tolerance of sublingual immunotherapy for aeroallergens in severe allergic asthmatic children controlled on omalizumab

Year: 2026

Type: article

Abstract: Real-world tolerance of sublingual immunotherapy for aeroallergens in severe allergic asthmatic children controlled on omalizumabTo the Editor, Asthma is the most common chronic disease in childhood, affecting approximately 10% of school-age children in France, 1 5%-10% with severe form.Severe asthma is defined by international guidelines (ERS/GINA) as uncontrolled asthma despite optimized treatment with high-dose inhaled corticosteroids (ICS) combined with long-

Source: Pediatric Allergy and Immunology

DOI: 10.1111/pai.70523

Authors: François Maury, Caroline Dufrois, Nathalie Lambert, Mélisande Bourgoin‐Heck, Stéphanie Wanin

Institutions: Sorbonne Université, Hôpital Armand-Trousseau, Assistance Publique – Hôpitaux de Paris

Language: English

Topic: Allergic Rhinitis and Sensitization

Subfield: Immunology and Allergy

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: hybrid

Estimated APC paid: $5,300